Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

Analysing the blood-stemming effect of Ankaferd Blood Stopper in medulla spinalis surgery

Pages
1131–1135
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ourfindings might precipitate the use of ABS on human subjects regarding medulla spinalis surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study was to investigate the possible toxicity of the Ankaferd Blood Stopper (ABS) on the neuralsystem.Materials and methods: Thirty Sprague Dawley rats were randomized into ABS (n: 15) and control (n: 15) groups.
📊
Key Findings & Data:One millilitre ABS was applied to the incision site inthe ABS group, and one millilitre 0.9% saline solution was applied in the control group.
💡
Conclusion & Impact:Ourfindings might precipitate the use of ABS on human subjects regarding medulla spinalis surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study was to investigate the possible toxicity of the Ankaferd Blood Stopper (ABS) on the neuralsystem.Materials and methods: Thirty Sprague Dawley rats were randomized into ABS (n: 15) and control (n: 15) groups. Following theanaesthetic induction, total laminectomy was performed to the lower thoracic, and upper lumbar areas in both groups and medullaspinalis was exposed. Two myelotomies were performed on the medulla spinalis. One millilitre ABS was applied to the incision site inthe ABS group, and one millilitre 0.9% saline solution was applied in the control group. Rats were observed for 15 days regarding generalbehaviour, neurological signs, mobility, and signs of infection. Sixteen days later, all rats were decapitated under anaesthesia. Medullaspinalis was removed en bloc from all rats and was stained with Heamatoxylin & Eosin and luxol fast blue.Results: There was no significant difference between the ABS group and the control group regarding oedema, gliosis, the intensity ofinflammatory cells, the presence of neuronal degeneration, neuron counts, and myelin degeneration.Conclusion: No clinical or histopathological evidence for the neurotoxic effect of the ABS was observed in the present study. Ourfindings might precipitate the use of ABS on human subjects regarding medulla spinalis surgery.

🔖

Cite This Article

DEMİREL, C., TÜRKÖZ, D., SATALOĞLU, H., ÇOKLUK, C. (2022). Analysing the blood-stemming effect of Ankaferd Blood Stopper in medulla spinalis surgery. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 1131–1135. https://ajindex.com/articles/609623

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bilgili H, Kosar A, Kurt M, Onal IK, Goker H et al. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Medical Principles and Practice 2009
  2. 18 (3): 165-169. doi: 10.1159/000204344 2. Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC et al. The efficacy of Ankaferd Blood Stopper in antithrombotic drug induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagulation and Fibrinolysis 2009
  3. 20 (3): 185-190. doi: 10.1097/MBC.0b013e32831c4cb0 3. Arslan S, Haznedaroglu IC, Oz B, Goker H. Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respiratory Medicine CME 2009
  4. 2 (3): 144-146. doi: 10.1016/j. rmedc.2008.10.016 4. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd blood stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008
  5. 40 (Suppl 2): E262. doi: 10.1055/s-2008-1077648 5. Rane K, Karlsten R, Sollevi A, Gordh T, Svensson BA. Spinal cord morphology after chronic intrathecal administration of adenosine in the rat. Acta Anaesthesiologica Scandinavica 1999
  6. 43 (10): 1035-1040. 6. Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesthesia and Analgesia 1999
  7. Arai T, Hoka S. Neurotoxicity of intrathecal local anesthetics. Journal of Anesthesia 2007
  8. 21 (4): 540-542. 8. Renkens KL, Payner TD, Leipzig TJ, Feuer H, Morone MA et al. A Multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 2001
  9. 26 (15): 1645-1650. 9. Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA et al. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery 2008
  10. 63 (4 Suppl 2): 369-372. doi: 10.1227/01.NEU.0000327031.98098.DD 10. Samudrala S. Topical hemostatic agents in surgery: a surgeon’s perspective. Association of Operating Room Nurses Journal 2008
  11. 88 (3): S2-11. doi: 10.1016/S0001-2092(08)00586-3 11. Sabel M, Stummer W. The use of local agents: Surgicel and Surgifoam. European Spine Journal 2004
  12. 13 (Suppl 1): S97- 101. 12. Sandrasegaran K, Lall C, Rajesh A, Maglinte D. Distinguishing gelatin bioabsorbable sponge and postoperative abdominal abscess on CT. American Journal of Roentgenology 2005
  13. 184 (2): 475-480. 13. Brodbelt AR, Miles JB, Foy PM, Broome JC. Intraspinal oxidised cel